BIO-TECHNE CORP (TECH) Fundamental Analysis & Valuation
NASDAQ:TECH • US09073M1045
Current stock price
52.36 USD
-6.22 (-10.62%)
Last:
This TECH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. TECH Profitability Analysis
1.1 Basic Checks
- TECH had positive earnings in the past year.
- In the past year TECH had a positive cash flow from operations.
- In the past 5 years TECH has always been profitable.
- Each year in the past 5 years TECH had a positive operating cash flow.
1.2 Ratios
- TECH's Return On Assets of 3.17% is fine compared to the rest of the industry. TECH outperforms 75.00% of its industry peers.
- With a decent Return On Equity value of 3.98%, TECH is doing good in the industry, outperforming 75.00% of the companies in the same industry.
- TECH has a better Return On Invested Capital (9.52%) than 89.29% of its industry peers.
- TECH had an Average Return On Invested Capital over the past 3 years of 9.00%. This is below the industry average of 11.80%.
- The 3 year average ROIC (9.00%) for TECH is below the current ROIC(9.52%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.17% | ||
| ROE | 3.98% | ||
| ROIC | 9.52% |
ROA(3y)6.63%
ROA(5y)7.59%
ROE(3y)8.82%
ROE(5y)10.28%
ROIC(3y)9%
ROIC(5y)9.64%
1.3 Margins
- TECH has a Profit Margin of 6.58%. This is in the better half of the industry: TECH outperforms 69.64% of its industry peers.
- TECH's Profit Margin has declined in the last couple of years.
- With an excellent Operating Margin value of 22.59%, TECH belongs to the best of the industry, outperforming 92.86% of the companies in the same industry.
- In the last couple of years the Operating Margin of TECH has remained more or less at the same level.
- TECH has a Gross Margin of 66.60%. This is amongst the best in the industry. TECH outperforms 87.50% of its industry peers.
- In the last couple of years the Gross Margin of TECH has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 22.59% | ||
| PM (TTM) | 6.58% | ||
| GM | 66.6% |
OM growth 3Y-6.91%
OM growth 5Y1.3%
PM growth 3Y-37.46%
PM growth 5Y-27.97%
GM growth 3Y-0.95%
GM growth 5Y0.33%
2. TECH Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so TECH is destroying value.
- The number of shares outstanding for TECH has been reduced compared to 1 year ago.
- Compared to 5 years ago, TECH has more shares outstanding
- The debt/assets ratio for TECH is higher compared to a year ago.
2.2 Solvency
- An Altman-Z score of 12.44 indicates that TECH is not in any danger for bankruptcy at the moment.
- TECH has a Altman-Z score of 12.44. This is amongst the best in the industry. TECH outperforms 96.43% of its industry peers.
- TECH has a debt to FCF ratio of 1.17. This is a very positive value and a sign of high solvency as it would only need 1.17 years to pay back of all of its debts.
- The Debt to FCF ratio of TECH (1.17) is better than 91.07% of its industry peers.
- TECH has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
- TECH has a Debt to Equity ratio of 0.13. This is in the better half of the industry: TECH outperforms 62.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | 1.17 | ||
| Altman-Z | 12.44 |
ROIC/WACC0.86
WACC11.07%
2.3 Liquidity
- A Current Ratio of 4.54 indicates that TECH has no problem at all paying its short term obligations.
- The Current ratio of TECH (4.54) is better than 75.00% of its industry peers.
- A Quick Ratio of 3.08 indicates that TECH has no problem at all paying its short term obligations.
- TECH has a Quick ratio of 3.08. This is in the better half of the industry: TECH outperforms 62.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.54 | ||
| Quick Ratio | 3.08 |
3. TECH Growth Analysis
3.1 Past
- TECH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.84%, which is quite good.
- The Earnings Per Share has been growing by 11.25% on average over the past years. This is quite good.
- TECH shows a small growth in Revenue. In the last year, the Revenue has grown by 1.64%.
- TECH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.55% yearly.
EPS 1Y (TTM)8.84%
EPS 3Y-0.77%
EPS 5Y11.25%
EPS Q2Q%9.52%
Revenue 1Y (TTM)1.64%
Revenue growth 3Y3.33%
Revenue growth 5Y10.55%
Sales Q2Q%0.24%
3.2 Future
- Based on estimates for the next years, TECH will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.61% on average per year.
- TECH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.10% yearly.
EPS Next Y4.8%
EPS Next 2Y7.28%
EPS Next 3Y9.92%
EPS Next 5Y8.61%
Revenue Next Year0.73%
Revenue Next 2Y3.52%
Revenue Next 3Y5.57%
Revenue Next 5Y7.1%
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. TECH Valuation Analysis
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 26.58 indicates a quite expensive valuation of TECH.
- TECH's Price/Earnings ratio is a bit cheaper when compared to the industry. TECH is cheaper than 71.43% of the companies in the same industry.
- The average S&P500 Price/Earnings ratio is at 27.50. TECH is around the same levels.
- Based on the Price/Forward Earnings ratio of 23.57, the valuation of TECH can be described as rather expensive.
- TECH's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. TECH is cheaper than 69.64% of the companies in the same industry.
- TECH is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.62, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.58 | ||
| Fwd PE | 23.57 |
4.2 Price Multiples
- 62.50% of the companies in the same industry are more expensive than TECH, based on the Enterprise Value to EBITDA ratio.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of TECH indicates a somewhat cheap valuation: TECH is cheaper than 62.50% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 36.73 | ||
| EV/EBITDA | 24.45 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates TECH does not grow enough to justify the current Price/Earnings ratio.
- The decent profitability rating of TECH may justify a higher PE ratio.
PEG (NY)5.54
PEG (5Y)2.36
EPS Next 2Y7.28%
EPS Next 3Y9.92%
5. TECH Dividend Analysis
5.1 Amount
- TECH has a yearly dividend return of 0.56%, which is pretty low.
- Compared to an average industry Dividend Yield of 0.11, TECH pays a better dividend. On top of this TECH pays more dividend than 92.86% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.81, TECH's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.56% |
5.2 History
- The dividend of TECH has a limited annual growth rate of 0.11%.
- TECH has been paying a dividend for at least 10 years, so it has a reliable track record.
- TECH has decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.11%
Div Incr Years0
Div Non Decr Years2
5.3 Sustainability
- 62.38% of the earnings are spent on dividend by TECH. This is not a sustainable payout ratio.
- TECH's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP62.38%
EPS Next 2Y7.28%
EPS Next 3Y9.92%
TECH Fundamentals: All Metrics, Ratios and Statistics
NASDAQ:TECH (4/23/2026, 12:10:01 PM)
52.36
-6.22 (-10.62%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-04 2026-02-04/bmo
Earnings (Next)05-06 2026-05-06/bmo
Inst Owners113.81%
Inst Owner Change-0.28%
Ins Owners0.26%
Ins Owner Change1.89%
Market Cap8.19B
Revenue(TTM)1.22B
Net Income(TTM)79.96M
Analysts80.87
Price Target76.73 (46.54%)
Short Float %9.04%
Short Ratio5.87
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.56% |
Yearly Dividend0.32
Dividend Growth(5Y)0.11%
DP62.38%
Div Incr Years0
Div Non Decr Years2
Ex-Date02-13 2026-02-13 (0.08)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.96%
Min EPS beat(2)-2.04%
Max EPS beat(2)3.95%
EPS beat(4)3
Avg EPS beat(4)3.35%
Min EPS beat(4)-2.04%
Max EPS beat(4)7.36%
EPS beat(8)6
Avg EPS beat(8)3.61%
EPS beat(12)6
Avg EPS beat(12)1.11%
EPS beat(16)7
Avg EPS beat(16)-2.33%
Revenue beat(2)0
Avg Revenue beat(2)-1.79%
Min Revenue beat(2)-3.53%
Max Revenue beat(2)-0.04%
Revenue beat(4)0
Avg Revenue beat(4)-1.87%
Min Revenue beat(4)-3.53%
Max Revenue beat(4)-0.04%
Revenue beat(8)3
Avg Revenue beat(8)-0.65%
Revenue beat(12)3
Avg Revenue beat(12)-1.76%
Revenue beat(16)4
Avg Revenue beat(16)-2.17%
PT rev (1m)0%
PT rev (3m)7.39%
EPS NQ rev (1m)-0.04%
EPS NQ rev (3m)-4.68%
EPS NY rev (1m)-0.23%
EPS NY rev (3m)0.14%
Revenue NQ rev (1m)0.11%
Revenue NQ rev (3m)-1.33%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.16%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.58 | ||
| Fwd PE | 23.57 | ||
| P/S | 6.74 | ||
| P/FCF | 36.73 | ||
| P/OCF | 32.86 | ||
| P/B | 4.07 | ||
| P/tB | 11.78 | ||
| EV/EBITDA | 24.45 |
EPS(TTM)1.97
EY3.76%
EPS(NY)2.22
Fwd EY4.24%
FCF(TTM)1.43
FCFY2.72%
OCF(TTM)1.59
OCFY3.04%
SpS7.77
BVpS12.85
TBVpS4.45
PEG (NY)5.54
PEG (5Y)2.36
Graham Number23.8694 (-54.41%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.17% | ||
| ROE | 3.98% | ||
| ROCE | 11.53% | ||
| ROIC | 9.52% | ||
| ROICexc | 10.26% | ||
| ROICexgc | 25.36% | ||
| OM | 22.59% | ||
| PM (TTM) | 6.58% | ||
| GM | 66.6% | ||
| FCFM | 18.35% |
ROA(3y)6.63%
ROA(5y)7.59%
ROE(3y)8.82%
ROE(5y)10.28%
ROIC(3y)9%
ROIC(5y)9.64%
ROICexc(3y)9.68%
ROICexc(5y)10.59%
ROICexgc(3y)24.93%
ROICexgc(5y)34.08%
ROCE(3y)10.9%
ROCE(5y)11.68%
ROICexgc growth 3Y-19.18%
ROICexgc growth 5Y-3.96%
ROICexc growth 3Y-9.13%
ROICexc growth 5Y5.53%
OM growth 3Y-6.91%
OM growth 5Y1.3%
PM growth 3Y-37.46%
PM growth 5Y-27.97%
GM growth 3Y-0.95%
GM growth 5Y0.33%
F-Score8
Asset Turnover0.48
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | 1.17 | ||
| Debt/EBITDA | 0.69 | ||
| Cap/Depr | 25.35% | ||
| Cap/Sales | 2.16% | ||
| Interest Coverage | 15.32 | ||
| Cash Conversion | 65.89% | ||
| Profit Quality | 278.92% | ||
| Current Ratio | 4.54 | ||
| Quick Ratio | 3.08 | ||
| Altman-Z | 12.44 |
F-Score8
WACC11.07%
ROIC/WACC0.86
Cap/Depr(3y)40.04%
Cap/Depr(5y)43.01%
Cap/Sales(3y)3.78%
Cap/Sales(5y)4.03%
Profit Quality(3y)188.66%
Profit Quality(5y)177.71%
High Growth Momentum
Growth
EPS 1Y (TTM)8.84%
EPS 3Y-0.77%
EPS 5Y11.25%
EPS Q2Q%9.52%
EPS Next Y4.8%
EPS Next 2Y7.28%
EPS Next 3Y9.92%
EPS Next 5Y8.61%
Revenue 1Y (TTM)1.64%
Revenue growth 3Y3.33%
Revenue growth 5Y10.55%
Sales Q2Q%0.24%
Revenue Next Year0.73%
Revenue Next 2Y3.52%
Revenue Next 3Y5.57%
Revenue Next 5Y7.1%
EBIT growth 1Y9.53%
EBIT growth 3Y-3.81%
EBIT growth 5Y11.98%
EBIT Next Year16.58%
EBIT Next 3Y12.12%
EBIT Next 5Y8.56%
FCF growth 1Y-1.07%
FCF growth 3Y-2.92%
FCF growth 5Y10.82%
OCF growth 1Y-9.8%
OCF growth 3Y-4.03%
OCF growth 5Y6.98%
BIO-TECHNE CORP / TECH Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for BIO-TECHNE CORP?
ChartMill assigns a fundamental rating of 6 / 10 to TECH.
What is the valuation status of BIO-TECHNE CORP (TECH) stock?
ChartMill assigns a valuation rating of 4 / 10 to BIO-TECHNE CORP (TECH). This can be considered as Fairly Valued.
Can you provide the profitability details for BIO-TECHNE CORP?
BIO-TECHNE CORP (TECH) has a profitability rating of 7 / 10.
Can you provide the financial health for TECH stock?
The financial health rating of BIO-TECHNE CORP (TECH) is 8 / 10.
What is the expected EPS growth for BIO-TECHNE CORP (TECH) stock?
The Earnings per Share (EPS) of BIO-TECHNE CORP (TECH) is expected to grow by 4.8% in the next year.